Craft

IBEX Technologies

Revenue

$7.5 M

FY, 2023

IBEX Technologies Summary

Company Summary

Overview
IBEX Technologies is a company that supplies reagents and components for critical care diagnostics. It manufactures and sells high-purity enzymes for in vitro diagnostics and ELISA kits for osteoarthritis research. The company focuses on custom fermentation as well as the filling and lyophilization of disposable diagnostic components.
Type
Subsidiary
Status
Active
Founded
1986
HQ
Montréal, CA | view all locations
Website
https://www.ibex.ca/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Danilo Netto, Director, Chairman of the Audit Committee and Member of the Governance Committee.

    • Robert J. Deluccia, Director, Chair of the Governance Committee and Member of the Audit Committee.

      LocationsView all

      1 location detected

      • Montréal, QC HQ

        Canada

        9475 Rue Meilleur #100

      IBEX Technologies Financials

      Summary Financials

      Revenue (Q2, 2024)
      $C1.9M
      Gross profit (Q2, 2024)
      $C1.5M
      Net income (Q2, 2024)
      $C50.0K
      Cash (Q2, 2024)
      $C8.7M
      EBIT (Q2, 2024)
      $C157.0K

      Footer menu